2023 EULAR recommendations on imaging in diagnosis and management of crystal-induced arthropathies in clinical practice
Annals of the Rheumatic Diseases (ARD)
is a leading rheumatology journal from EULAR, publishing original research, reviews and recommendations
Impact Factor: 27.4
Citescore: 32.8
All metrics >>
Latest EULAR Recommendations
EULAR recommendations for the non-pharmacological core management of hip and knee osteoarthritis: 2023 update
2023 EULAR recommendations for the management of fatigue in people with inflammatory rheumatic and musculoskeletal diseases
EULAR recommendations for the management of systemic lupus erythematosus: 2023 update
Authors
Annals of the Rheumatic Diseases considers unsolicited submissions of a variety of article types, including original research articles (extended and concise reports), viewpoints, and letters to the Editor.
The Author Information section provides general guidelines and requirements for specific article types.
Information is also provided on editorial policies and open access.
Latest Articles
Correspondence:
Correspondence on 'Current myositis clinical trials and tribulations by Saygin et al28 March 2024
Correspondence response:
Response to: Correspondence on 'Current myositis clinical trials and tribulations by Saygin et al28 March 2024
Imaging:
Validation and incorporation of digital entheses into a preliminary GLobal OMERACT Ultrasound DActylitis Score (GLOUDAS) in psoriatic arthritis26 March 2024
Systemic lupus erythematosus:
Characterisation of choroid plexus-infiltrating T cells reveals novel therapeutic targets in murine neuropsychiatric lupus26 March 2024
Recommendations
The EULAR Standing Committees regularly establish and publish recommendations for the treatment of various rheumatic disorders. Each of these recommendations is developed by a group of specialists in their field.
All EULAR recommendations are free to access.
Each recommendation also has an accompanying lay summary, which is also free to access.
Video
CD7 activation regulates cytotoxicity-driven pathology in systemic sclerosis
Conclusion: Together, the findings imply costimulatory molecules as key regulators of cytotoxicity-driven pathology in systemic autoimmune disease, yielding CD7 as a novel target for selective depletion of pathogenic cells.
Find out moreAltmetrics
Jobs
Isle of Man (GB) (IM)
We’re looking for a Consultant Histopathologist to join our small, forward-thinking and dedicated team in the Pathology department within Manx Care.Recruiter: Isle of Man Government Secondary Care
Consultant Paediatrician
Isle of Man (GB) (IM)
We are seeking to appoint a knowledgeable, driven and forward-thinking Consultant Paediatrician to join our supportive team at Noble’s Hospital!Recruiter: Isle of Man Government Secondary Care
Consultant in DM/Endocrinology and Acute Medicine
Dundee City
Applications are invited for a Consultant Endocrinologist based at Ninewells Hospital in Dundee. This post is to enhance the delivery and developme...Recruiter: NHS Tayside
Salaried GP - Millbrook Surgery
Castle Cary, Somerset
Due to our continued growth a rare chance has arisen to join our team at Millbrook Surgery.Recruiter: Millbrook Surgery
Salaried GP
Newcastle Upon Tyne, Tyne and Wear
We provide a safe and well supported working environment so you can focus on providing great clinical care to patientsRecruiter: Westerhope Medical Group